UBS Group Boosts UnitedHealth Group (NYSE:UNH) Price Target to $430.00

UnitedHealth Group (NYSE:UNH) had its target price boosted by stock analysts at UBS Group from $378.00 to $430.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the healthcare conglomerate’s stock. UBS Group’s price objective would suggest a potential upside of 24.79% from the stock’s current price.

A number of other research firms have also issued reports on UNH. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a report on Wednesday. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Barclays upped their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Finally, Robert W. Baird reiterated an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Stock Down 3.0%

UNH stock opened at $344.57 on Wednesday. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a market cap of $312.07 billion, a PE ratio of 17.98, a P/E/G ratio of 2.28 and a beta of 0.47. The firm has a 50 day simple moving average of $342.82 and a 200 day simple moving average of $331.10. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the previous year, the business earned $7.15 earnings per share. The firm’s revenue was up 12.2% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Institutional Trading of UnitedHealth Group

Several large investors have recently added to or reduced their stakes in UNH. Vanguard Group Inc. boosted its holdings in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP boosted its holdings in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the period. Geode Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock worth $6,624,411,000 after buying an additional 675,075 shares during the period. Norges Bank bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth $3,837,207,000. Finally, Dodge & Cox boosted its holdings in shares of UnitedHealth Group by 117.7% during the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock worth $2,729,912,000 after buying an additional 4,730,192 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.